Cargando…
Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016
By 2050, the world would need to produce 1,250 million tonnes of meat and dairy per year to meet global demand for animal-derived protein at current consumption levels. However, growing demand for protein will not be met sustainably by increasing meat and dairy production because of the low efficien...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645522/ https://www.ncbi.nlm.nih.gov/pubmed/29081772 http://dx.doi.org/10.3389/fmicb.2017.02009 |
_version_ | 1783271909960450048 |
---|---|
author | Ritala, Anneli Häkkinen, Suvi T. Toivari, Mervi Wiebe, Marilyn G. |
author_facet | Ritala, Anneli Häkkinen, Suvi T. Toivari, Mervi Wiebe, Marilyn G. |
author_sort | Ritala, Anneli |
collection | PubMed |
description | By 2050, the world would need to produce 1,250 million tonnes of meat and dairy per year to meet global demand for animal-derived protein at current consumption levels. However, growing demand for protein will not be met sustainably by increasing meat and dairy production because of the low efficiency of converting feed to meat and dairy products. New solutions are needed. Single cell protein (SCP), i.e., protein produced in microbial and algal cells, is an option with potential. Much of the recent interest in SCP has focused on the valorisation of side streams by using microorganisms to improve their protein content, which can then be used in animal feed. There is also increased use of mixed populations, rather than pure strains in the production of SCP. In addition, the use of methane as a carbon source for SCP is reaching commercial scales and more protein-rich products are being derived from algae for both food and feed. The following review addresses the latest developments in SCP production from various organisms, giving an overview of commercial exploitation, a review of recent advances in the patent landscape (2001–2016) and a list of industrial players in the SCP field. |
format | Online Article Text |
id | pubmed-5645522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56455222017-10-27 Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016 Ritala, Anneli Häkkinen, Suvi T. Toivari, Mervi Wiebe, Marilyn G. Front Microbiol Microbiology By 2050, the world would need to produce 1,250 million tonnes of meat and dairy per year to meet global demand for animal-derived protein at current consumption levels. However, growing demand for protein will not be met sustainably by increasing meat and dairy production because of the low efficiency of converting feed to meat and dairy products. New solutions are needed. Single cell protein (SCP), i.e., protein produced in microbial and algal cells, is an option with potential. Much of the recent interest in SCP has focused on the valorisation of side streams by using microorganisms to improve their protein content, which can then be used in animal feed. There is also increased use of mixed populations, rather than pure strains in the production of SCP. In addition, the use of methane as a carbon source for SCP is reaching commercial scales and more protein-rich products are being derived from algae for both food and feed. The following review addresses the latest developments in SCP production from various organisms, giving an overview of commercial exploitation, a review of recent advances in the patent landscape (2001–2016) and a list of industrial players in the SCP field. Frontiers Media S.A. 2017-10-13 /pmc/articles/PMC5645522/ /pubmed/29081772 http://dx.doi.org/10.3389/fmicb.2017.02009 Text en Copyright © 2017 Ritala, Häkkinen, Toivari and Wiebe. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Ritala, Anneli Häkkinen, Suvi T. Toivari, Mervi Wiebe, Marilyn G. Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016 |
title | Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016 |
title_full | Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016 |
title_fullStr | Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016 |
title_full_unstemmed | Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016 |
title_short | Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016 |
title_sort | single cell protein—state-of-the-art, industrial landscape and patents 2001–2016 |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645522/ https://www.ncbi.nlm.nih.gov/pubmed/29081772 http://dx.doi.org/10.3389/fmicb.2017.02009 |
work_keys_str_mv | AT ritalaanneli singlecellproteinstateoftheartindustriallandscapeandpatents20012016 AT hakkinensuvit singlecellproteinstateoftheartindustriallandscapeandpatents20012016 AT toivarimervi singlecellproteinstateoftheartindustriallandscapeandpatents20012016 AT wiebemarilyng singlecellproteinstateoftheartindustriallandscapeandpatents20012016 |